US Patent Issued to MEDICINAL BIOCONVERGENCE RESEARCH CENTER on Nov. 20 for "Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis" (South Korean Inventors)

Press/Media: Press / Media

Period2018 Nov 20

Media coverage

1

Media coverage

  • TitleUS Patent Issued to MEDICINAL BIOCONVERGENCE RESEARCH CENTER on Nov. 20 for "Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis" (South Korean Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date18/11/20
    PersonsSunghoon Kim